Market Currents
Molecular diagnostics firm Cepheid (CPHD) up 6% AH as it gets FDA clearance for a test that...
-
Thursday, September 24, 2009, 4:45 PM ETMolecular diagnostics firm Cepheid (CPHD) up 6% AH as it gets FDA clearance for a test that detects genetic variations related to an increased risk of blood clots. (PR)
Other date
Latest Articles
This news story has 1 comment: